Genetic Signatures Ltd (GSS) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.008x

Based on the latest financial reports, Genetic Signatures Ltd (GSS) has a cash flow conversion efficiency ratio of -0.008x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-349.00K ≈ $-246.94K USD) by net assets (AU$44.09 Million ≈ $31.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See GSS equity financing ratio to measure how much of total assets are equity-financed.

Genetic Signatures Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Genetic Signatures Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check GSS cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Genetic Signatures Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genetic Signatures Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Quantum Helium Limited LSE:QHE	-0.096x
Hengli Industrial Development Group Co Ltd SHE:000622	-0.027x
Regency Ceramics Limited NSE:REGENCERAM	0.182x
Snipp Interactive Inc V:SPN	-0.018x
Metals Australia Ltd AU:MLS	-0.014x
North Arrow Minerals Inc V:NAR	-0.011x
Silver Range Resources Ltd V:SNG	-0.019x
Wonpung Mulsan Co.Ltd KQ:008290	-0.087x

Annual Cash Flow Conversion Efficiency for Genetic Signatures Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Genetic Signatures Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Genetic Signatures Ltd (GSS) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$50.09 Million ≈ $35.44 Million	AU$-12.29 Million ≈ $-8.70 Million	-0.245x	-48.12%
2024-06-30	AU$61.10 Million ≈ $43.23 Million	AU$-10.12 Million ≈ $-7.16 Million	-0.166x	+42.92%
2023-06-30	AU$42.91 Million ≈ $30.36 Million	AU$-12.45 Million ≈ $-8.81 Million	-0.290x	-262.15%
2022-06-30	AU$54.80 Million ≈ $38.78 Million	AU$9.81 Million ≈ $6.94 Million	0.179x	+110.46%
2021-06-30	AU$49.34 Million ≈ $34.91 Million	AU$4.20 Million ≈ $2.97 Million	0.085x	+141.13%
2020-06-30	AU$45.93 Million ≈ $32.50 Million	AU$-9.49 Million ≈ $-6.72 Million	-0.207x	+3.71%
2019-06-30	AU$10.57 Million ≈ $7.48 Million	AU$-2.27 Million ≈ $-1.61 Million	-0.215x	+22.12%
2018-06-30	AU$13.40 Million ≈ $9.48 Million	AU$-3.69 Million ≈ $-2.61 Million	-0.276x	-76.69%
2017-06-30	AU$16.49 Million ≈ $11.66 Million	AU$-2.57 Million ≈ $-1.82 Million	-0.156x	+71.62%
2016-06-30	AU$4.68 Million ≈ $3.31 Million	AU$-2.57 Million ≈ $-1.82 Million	-0.550x	-38.78%
2015-06-30	AU$7.06 Million ≈ $4.99 Million	AU$-2.80 Million ≈ $-1.98 Million	-0.396x	-372.97%
2014-06-30	AU$16.18 Million ≈ $11.45 Million	AU$-1.35 Million ≈ $-958.56K	-0.084x	-123.40%
2013-06-30	AU$-3.32 Million ≈ $-2.35 Million	AU$-1.19 Million ≈ $-839.81K	0.358x	--

About Genetic Signatures Ltd

AU:GSS Australia Diagnostics & Research

Market Cap

$9.32 Million

AU$13.17 Million AUD

Market Cap Rank

#27237 Global

#1327 in Australia

Share Price

AU$0.06

Change (1 day)

+0.00%

52-Week Range

AU$0.05 - AU$0.38

All Time High

AU$2.75